Silverfin false false 30/09/2024 01/10/2023 30/09/2024 L Moranzoni 08/03/2019 S M Moranzoni 08/03/2019 23 April 2025 The principal activity of the company is the provision of dental endodontic services. 11868637 2024-09-30 11868637 bus:Director1 2024-09-30 11868637 bus:Director2 2024-09-30 11868637 2023-09-30 11868637 core:CurrentFinancialInstruments 2024-09-30 11868637 core:CurrentFinancialInstruments 2023-09-30 11868637 core:Non-currentFinancialInstruments 2024-09-30 11868637 core:Non-currentFinancialInstruments 2023-09-30 11868637 core:ShareCapital 2024-09-30 11868637 core:ShareCapital 2023-09-30 11868637 core:RetainedEarningsAccumulatedLosses 2024-09-30 11868637 core:RetainedEarningsAccumulatedLosses 2023-09-30 11868637 core:ToolsEquipment 2023-09-30 11868637 core:ToolsEquipment 2024-09-30 11868637 core:CostValuation 2023-09-30 11868637 core:CostValuation 2024-09-30 11868637 core:CurrentFinancialInstruments core:Secured 2024-09-30 11868637 2023-10-01 2024-09-30 11868637 bus:FilletedAccounts 2023-10-01 2024-09-30 11868637 bus:SmallEntities 2023-10-01 2024-09-30 11868637 bus:AuditExemptWithAccountantsReport 2023-10-01 2024-09-30 11868637 bus:PrivateLimitedCompanyLtd 2023-10-01 2024-09-30 11868637 bus:Director1 2023-10-01 2024-09-30 11868637 bus:Director2 2023-10-01 2024-09-30 11868637 core:ToolsEquipment core:TopRangeValue 2023-10-01 2024-09-30 11868637 2022-10-01 2023-09-30 11868637 core:ToolsEquipment 2023-10-01 2024-09-30 11868637 core:Subsidiary1 2023-10-01 2024-09-30 11868637 core:Subsidiary1 1 2023-10-01 2024-09-30 11868637 core:Subsidiary1 1 2022-10-01 2023-09-30 11868637 core:CurrentFinancialInstruments 2023-10-01 2024-09-30 11868637 core:Non-currentFinancialInstruments 2023-10-01 2024-09-30 iso4217:GBP xbrli:pure decimalUnit

Company No: 11868637 (England and Wales)

MALDIDENTI LIMITED

Unaudited Financial Statements
For the financial year ended 30 September 2024
Pages for filing with the registrar

MALDIDENTI LIMITED

Unaudited Financial Statements

For the financial year ended 30 September 2024

Contents

MALDIDENTI LIMITED

BALANCE SHEET

As at 30 September 2024
MALDIDENTI LIMITED

BALANCE SHEET (continued)

As at 30 September 2024
Note 2024 2023
£ £
Fixed assets
Tangible assets 3 469 3,001
Investments 4 292,200 292,200
292,669 295,201
Current assets
Debtors 5 6,963 8,104
Cash at bank and in hand 46,671 97,732
53,634 105,836
Creditors: amounts falling due within one year 6 ( 28,795) ( 27,492)
Net current assets 24,839 78,344
Total assets less current liabilities 317,508 373,545
Creditors: amounts falling due after more than one year 7 ( 139,324) ( 165,348)
Net assets 178,184 208,197
Capital and reserves
Called-up share capital 1,000 1,000
Profit and loss account 177,184 207,197
Total shareholders' funds 178,184 208,197

For the financial year ending 30 September 2024 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The financial statements of Maldidenti Limited (registered number: 11868637) were approved and authorised for issue by the Board of Directors on 23 April 2025. They were signed on its behalf by:

L Moranzoni
Director
MALDIDENTI LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 30 September 2024
MALDIDENTI LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 30 September 2024
1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial year, unless otherwise stated.

General information and basis of accounting

Maldidenti Limited (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is Lowin House, Tregolls Road, Truro, TR1 2NA, United Kingdom.

The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

Going concern

The directors have assessed the Balance Sheet and likely future cash flows at the date of approving these financial statements. The directors have a reasonable expectation that the Company has adequate resources to continue in operational existence and to meet its financial obligations as they fall due for at least 12 months from the date of signing these financial statements. Accordingly, they continue to adopt the going concern basis in preparing the financial statements.

Turnover

Turnover comprises the fair value of the consideration received or receivable for the provision of services in the ordinary course of the company's activities.

The company recognises revenue when:

The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Taxation

Current tax
Current tax is provided at amounts expected to be paid (or recoverable) using the tax rates and laws that have been enacted or substantively enacted at the Balance Sheet date.

Tangible fixed assets

Tangible fixed assets are stated at cost or valuation, net of depreciation and any provision for impairment. Depreciation is provided on all tangible fixed assets, other than investment property and freehold land, at rates calculated to write off the cost or valuation, less estimated residual value, of each asset on a straight-line basis over its expected useful life, as follows:

Tools and equipment 3 years straight line
Fixed asset investments

Investments in equity shares which are publicly traded or where the fair value can be measured reliably are initially measured at fair value, with changes in fair value recognised in profit or loss
Investments in equity shares which are not publicly traded and where fair value cannot be measured reliably are measured at cost less impairment.

Interest income on debt securities, where applicable, is recognised in income using the effective interest method. Dividends on equity securities are recognised in income when receivable.

Financial instruments

Financial assets and financial liabilities are recognised when the Company becomes a party to the contractual provisions of the instrument.

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after deducting all of its liabilities.

Financial assets and liabilities are only offset in the Balance Sheet when, and only when there exists a legally enforceable right to set off the recognised amounts and the Company intends either to settle on a net basis, or to realise the asset and settle the liability simultaneously.

2. Employees

2024 2023
Number Number
Monthly average number of persons employed by the Company during the year, including directors 1 1

3. Tangible assets

Tools and equipment Total
£ £
Cost
At 01 October 2023 10,013 10,013
At 30 September 2024 10,013 10,013
Accumulated depreciation
At 01 October 2023 7,012 7,012
Charge for the financial year 2,532 2,532
At 30 September 2024 9,544 9,544
Net book value
At 30 September 2024 469 469
At 30 September 2023 3,001 3,001

4. Fixed asset investments

Investments in subsidiaries

2024
£
Cost
At 01 October 2023 292,200
At 30 September 2024 292,200
Carrying value at 30 September 2024 292,200
Carrying value at 30 September 2023 292,200

Investments in shares

Name of entity Registered office Principal activity Class of
shares
Ownership
30.09.2024
Ownership
30.09.2023
Circus Dental Limited Lowin House, Tregolls Road, Truro, TR1 2NA - England & Wales Dental practice activities Ordinary D 20.00% 20.00%
Contemporary Endodontics Limited Lowin House, Tregolls Road, Truro, TR1 2NA - England & Wales Other education and manufacture of dental instruments and supplies Ordinary A 50.00% 50.00%

5. Debtors

2024 2023
£ £
Amounts owed by Group undertakings 5,850 1,750
Corporation tax 0 3,197
Other debtors 1,113 3,157
6,963 8,104

6. Creditors: amounts falling due within one year

2024 2023
£ £
Bank loans (secured) 26,025 24,940
Accruals 2,770 2,552
28,795 27,492

The bank loans are secured by a personal guarantee from the directors.

7. Creditors: amounts falling due after more than one year

2024 2023
£ £
Bank loans (secured) 139,324 165,348

The bank loans are secured by a personal guarantee from the directors.

8. Related party transactions

Transactions with entities in which the entity itself has a participating interest

2024 2023
£ £
Amounts owed (to)/from Contemporary Endodontics Limited 5,850 1,750

Transactions with the entity's directors

2024 2023
£ £
At 1 October 2023 2,057 (205)
Advances to directors 368 2,574
Repayments by directors (2,412) (312)
At 30 September 2024 13 2,057